WEDNESDAY, Sept. 30, 2020 (HealthDay News) — Elderly people who get COVID-19 have lower levels of important immune cells, which may explain why they are more likely than younger patients to have severe symptoms or die, new research suggests. For the study, the researchers analyzed blood samples from 30 peopleContinue Reading
THURSDAY, Sept. 24, 2020 (HealthDay News) — Children who need to take oral steroids for chronic or life-threatening conditions can experience serious side effects, according to new research. Children with autoimmune disorders such as juvenile arthritis, psoriasis or inflammatory bowel disease are often prescribed a steroid to keep the illnessContinue Reading
WEDNESDAY, Sept. 16, 2020 (HealthDay News) — A drug long used to treat Parkinson’s disease may benefit patients with a severe form of age-related macular degeneration (AMD), a small clinical trial suggests. One of the leading causes of vision loss in older people is a condition called dry macular degeneration.Continue Reading
FRIDAY, Sept. 4, 2020 (HealthDay News) — People with lupus aren’t at increased risk of hospitalization from COVID-19 due to steroidal medications they take to reduce immune system activity, a new study finds. And a related study found that people with inflammatory forms of arthritis — such as rheumatoid arthritisContinue Reading
TUESDAY, July 28, 2020 (HealthDay News) — People with a history of concussion may face increased risks of certain psychological and neurological conditions, a large new study suggests. The study of more than 186,000 Canadians found that those who suffered a concussion were more likely to develop any of severalContinue Reading
WEDNESDAY, July 1, 2020 (HealthDay News) — A blood test may predict which COVID-19 patients are likely to need a ventilator. This finding could lead to a scoring system that would flag at-risk patients for closer monitoring and to personalized treatments. It may also help explain how diabetes makes outcomesContinue Reading
WEDNESDAY, June 24, 2020 (HealthDay News) — There’s new evidence that a 2,000-year-old medicine might offer hope against a modern scourge: COVID-19. The medication, called colchicine, is an anti-inflammatory taken as a pill. It’s long been prescribed for gout, a form of arthritis, and its history goes back centuries. TheContinue Reading
WEDNESDAY, June 24, 2020 (HealthDay News) — In findings that could pave the way to a new treatment for Parkinson’s disease, scientists have figured out how to spur the production of new brain cells in mice. The advance centers on a protein found in various cells in mice and humans.Continue Reading
FRIDAY, June 19, 2020 (HealthDay News) — It often seems the older a person gets, the less they sleep, but new research suggests that inconsistent sleep patterns might predict a future diagnosis of Parkinson’s disease. Researchers who studied 2,930 older men for more than a decade found that those withContinue Reading
TUESDAY, June 2, 2020 (HealthDay News) — A drug championed by President Donald Trump as a coronavirus panacea appears to be in short supply for people who really need it: lupus patients. More than one-third of U.S. lupus patients who take hydroxychloroquine have struggled to fill prescriptions for the drugContinue Reading
WEDNESDAY, May 27, 2020 (HealthDay News) — Mindfulness training may help counter the thinking and emotional difficulties caused by multiple sclerosis. In a small test study, people with multiple sclerosis (MS) who had four weeks of mindfulness training emerged with better emotional control and faster thinking. Multiple sclerosis is aContinue Reading
TUESDAY, May 26, 2020 (HealthDay News) — Air pollution might increase the risk for multiple sclerosis (MS), Italian researchers report. They found that in places with low levels of tiny particles of air pollution called particulate matter, the risk for MS was lower than in areas where those levels wereContinue Reading
FRIDAY, May 1, 2020 (HealthDay News) — The severity of COVID-19 illness may be influenced by what researchers call “cytokine storms.” In a new study, investigators assessed 522 COVID-19 patients, aged 5 days to 97 years, who were admitted to two hospitals in Wuhan, China, in December and January. TheContinue Reading
SATURDAY, April 25, 2020 (HealthDay News) — Hydroxychloroquine is a key therapy for the autoimmune disease lupus, but interest in it as a potential COVID-19 treatment could make it hard for lupus patients to obtain, experts warn. Hydroxychloroquine is the only medication known to increase survival in patients with systemicContinue Reading